Published in Folia Biol (Krakow) on January 01, 1969
Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages. J Exp Med (1979) 5.47
Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol (1980) 3.09
2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect. J Exp Med (1976) 2.80
Interactions of human cytomegalovirus with human fibroblasts. J Bacteriol (1966) 2.00
Thymidine-kinase in cytomegalovirus infected cells. Arch Virol (1976) 1.96
Fc receptor modulation in mononuclear phagocytes maintained on immobilized immune complexes occurs by diffusion of the receptor molecule. J Exp Med (1983) 1.90
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
Pathogenesis of acute and persistent murine herpesvirus infection in mice. Acta Virol (1985) 1.78
Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease. Eur J Clin Invest (1999) 1.71
Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol (1966) 1.71
Tubulin and actin topology during zygote formation of Saccharomyces cerevisiae. J Gen Microbiol (1987) 1.64
Thermoinactivation of human cytomegalovirus. J Bacteriol (1966) 1.56
A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab (2000) 1.55
Modulation of Fc receptors of mononuclear phagocytes by immobilized antigen-antibody complexes. Quantitative analysis of the relationship between ligand number and Fc receptor response. J Exp Med (1983) 1.45
Human cytomegalovirus: properties of the complement-fixing antigen. J Immunol (1966) 1.44
Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. J Natl Cancer Inst (1970) 1.43
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland. Bull World Health Organ (1972) 1.42
Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. Neoplasma (1986) 1.36
Ribonucleotides linked to DNA of herpes simplex virus type 1. J Virol (1974) 1.28
Papovaviridae. Intervirology (1974) 1.26
Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization. J Cell Biol (1984) 1.22
Molecular dynamics of a grid-mounted molecular dipolar rotor in a rotating electric field. Proc Natl Acad Sci U S A (2001) 1.18
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer (1984) 1.14
Association of some supraglottic laryngeal carcinomas with EB virus. Int J Cancer (1983) 1.07
Bicyclo[1.1.1]pentanes, [n]Staffanes, [1.1.1]Propellanes, and Tricyclo[2.1.0.0(2,5)]pentanes. Chem Rev (2000) 1.06
Studies on the growth of herpes simplex virus in lymphoblastoid cells. Acta Virol (1971) 1.06
Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus. J Natl Cancer Inst (1973) 1.05
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ (1975) 1.03
Replicating DNA of herpes simplex virus type 1. Intervirology (1976) 1.03
Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J Natl Cancer Inst (1984) 1.00
Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells. Proc Natl Acad Sci U S A (2001) 0.99
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology (2001) 0.98
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence. J Natl Cancer Inst (1974) 0.97
Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology (1980) 0.92
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
The use of an in vitro test of delayed type hypersensitivity for the detection of specific tumor antigen of transplantation type induced by SV 40 virus. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.91
Growth characteristics of herpesviruses isolated from free living small rodents. Acta Virol (1982) 0.90
Replication of cytomegalovirus in human epitheloid diploid cell line. Arch Virol (1976) 0.90
Osmoregulation in Bacillus subtilis under potassium limitation: a new inducible K+-stimulated, VO4(3-)-inhibited ATPase. Can J Microbiol (2001) 0.89
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Res (1990) 0.89
A monoclonal antibody to a human neutrophil-specific plasma membrane antigen. Effect of the antibody on the C3bi-mediated adherence by neutrophils and expression of the antigen during myelopoiesis. J Exp Med (1988) 0.88
Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture. Acta Virol (1968) 0.88
[Antigenicity of hapten-polysaccharide conjugates]. Eur J Immunol (1971) 0.88
Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol (1988) 0.88
Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. J Gen Virol (1991) 0.87
Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens. J Infect Dis (1984) 0.87
Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen. Arch Gesamte Virusforsch (1967) 0.87
Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch Virol (1984) 0.87
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer (1984) 0.86
Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J Gen Virol (1990) 0.86
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch (1967) 0.86
Immunofluorescence of the microtubular skeleton in growing and drug-treated yeast protoplasts. Eur J Cell Biol (1986) 0.86
DnaK and GroEL chaperones are recruited to the Bacillus subtilis membrane after short-term ethanol stress. J Appl Microbiol (2012) 0.86
Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems. I. Derivation and neurotropic activity of NWS virus lines. Arch Gesamte Virusforsch (1968) 0.86
Multiplicity reactivation in UV-irradiated herpes simplex type 1 virus. Intervirology (1973) 0.85
Human papillomavirus infection and cervical carcinoma. Clin Obstet Gynecol (2000) 0.85
Tetramesityldisilene, a stable compound containing a silicon-silicon double bond. Science (1981) 0.85
Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia. Int J Cancer (1996) 0.85
A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol (1967) 0.85
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol (1997) 0.84
Linkage between reproductive capacity at increased temperature and neurotropic activity in A-NWS HONi (HON1) influenza virus. Infect Immun (1974) 0.84
Evidence that excitatory amino acids not only activate the receptor channel complex but also lead to use-dependent block. Brain Res (1986) 0.84
Biochemical characteristics of collagen produced by long term cultivated amniotic fluid cells. Hum Genet (1976) 0.84
Carbamyl phosphate as an essential component of the flattening factor for cells in culture. Nature (1965) 0.83
Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol (1981) 0.83
Plaque formation by NWS influenza virus in a human diploid cell strain. Acta Virol (1967) 0.83
Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants. Arch Virol (1998) 0.83
Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer (1998) 0.83
Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch (1965) 0.83
Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients. Int J Cancer (1972) 0.83
The distribution of perforin in normal tissues. Immunol Lett (1991) 0.83
Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res (1987) 0.83
Cold shock in Bacillus subtilis: different effects of benzyl alcohol and ethanol on the membrane organisation and cell adaptation. Biochim Biophys Acta (2000) 0.83
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine (1995) 0.83
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br J Cancer (2001) 0.82
Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Arch Gesamte Virusforsch (1970) 0.82
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16. Int J Oncol (1999) 0.82
Structure of herpes simplex virus DNA: topography of the molecule. I. Absence of circularly permuted sequences. Virology (1975) 0.82
Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years. Arch Gesamte Virusforsch (1972) 0.82
Electron microscopy of binding of Epstein-Barr virus (EBV) nuclear antigen (EBNA-1) to EBV DNA. Virology (1987) 0.81
Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex Transm Infect (2003) 0.81
Genetic interaction between two influenza A-WS virus mutants. I. Characterization of the mutants. Acta Virol (1971) 0.81
Production and some properties of neutralizing antigens of herpes simplex virus. Acta Virol (1977) 0.81
Changes in serum and tissue fibronectin during ontogeny. Physiol Bohemoslov (1983) 0.81
A method for the preparation of purified antigens of coxsackievirus B3 from a large volume of cell culture supernatant. Acta Virol (1992) 0.81
Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J Infect Dis (1994) 0.81
Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J Gen Virol (1982) 0.81
Genetic interaction between two influenza A-WS virus mutants. II. Genetic interaction between NWS-D and WS-MK viruses in human diploid cells and hamster embryo fibroblasts. Acta Virol (1971) 0.81
Ultrastructural changes induced by influenza viruses in permissive and nonpermissive cells. Virology (1977) 0.81
The nature of adenovirus persistence in human adenoid vegetations. Arch Virol (1975) 0.80
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours. Int J Oncol (2003) 0.80